Document text
Principal Investigator: Jeremy David Keenan
Organization: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Fiscal Year: 2024
Award: $1,448,874
Funding agency: National Eye Institute
PROJECT SUMMARY/ABSTRACT
The World Health Organization estimates that 80% of blindness worldwide is avoidable. However, in
resource-limited settings progressive eye diseases such as glaucoma, diabetic retinopathy (DR), and age-related
macular degeneration (AMD) often go undiagnosed until it is too late. New approaches that detect progressive
eye diseases before they cause irreversible vision loss could help reduce visual impairment of communities. One
such approach is community-based eye disease screening. The Village Integrated Eye Workers Trial II (VIEW
II) is an ongoing cluster-randomized trial in which communities in Nepal receive visual acuity screening and are
subsequently randomized to receive either a community-based eye disease screening intervention consisting of
optical coherence tomography (OCT) and intraocular pressure (IOP) assessment, or to no intervention. The goal
of the screening intervention is to detect cases of glaucoma, diabetic retinopathy, and age-related macular
degeneration—all of which are progressive and cause irreversible vision loss if left untreated—and refer these
cases to the local eye hospital for management. A door-to-door census is performed four years after starting the
screening intervention to determine the effectiveness of screening for reducing vision impairment relative to
communities not receiving the screening intervention.
This is a proposal for the extension of the VIEW II trial, maintaining the original randomization and
continuing the same screening intervention in the study clusters except that fundus photography is also included
in the screening intervention and that the targeted age group is expanded to those ≥50 years. The specific aims
of the proposal are (1) to determine if the screening intervention is effective for preventing vision loss at the
community level over 7 years, (2) to compare text messages versus community volunteers for improving linkage
to care, and (3) to determine the natural history of OCT measurements over time in a population-based study.
Glaucoma, DR, and AMD are slowly progressive diseases, and given interruptions to study activities caused by
the COVID-19 pandemic, the originally planned 4-year endpoint in the original VIEW II trial may not be long
enough to observe the full effect of the screening intervention. Extending the trial will provide a more accurate
assessment of any benefit of screening. Extending the trial also allows for repeated OCTs in a population-based
sample, providing much needed data on the natural history of OCT parameters to help clinicians better determine
what constitutes progression. This research is significant because it will provide the strongest type of evidence
to guide national eye health programs – results from a randomized controlled trial. Ultimately, this trial will benefit
blindness prevention programs worldwide in deciding how to allocate limited resources to optimally detect eye
disease.
Terms: <Active Follow-up><Address><Adherence><Age related macular degeneration><Age-Related Maculopathy><Blindness><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><CV-19><Caring><Censuses><Cluster randomization trial><Cluster randomized trial><Communities><Coronavirus Infectious Disease 2019><Data><Detection><Diabetic Retinopathy><Diminished Vision><Disease><Disorder><Doppler OCT><Effectiveness><Effectiveness of Interventions><Enrollment><Eye><Eye diseases><Eyeball><Funding><Fundus photography><General Population><General Public><Glaucoma><Goals><Health><Home visitation><Hospital Administration><Hospital Management><Hospitals><House Call><Impairment><Individual><Infrastructure><Institution><Interruption><Intervention><Intervention Strategies><Intraocular Pressure><Intuition><Investigators><Left><Low Prevalence><Low Vision><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Measurement><Natural History><Nepal><OCT Tomography><Ocular Tension><Older Population><Optical Coherence Tomography><Outcome><Partial Sight><Participant><Patients><Persons><Physiologic Intraocular Pressure><Policy Maker><Population Study><Prevention><Prevention program><Progressive Disease><Public Health><RNFL><Randomized><Randomized, Controlled Trials><Recommendation><Reduced Vision><Research><Research Personnel><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Running><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Sample Size><Sampling><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Specific qualifier value><Specified><Subnormal Vision><System><Telemedicine><Testing><Text Messaging><Thick><Thickness><Time><Visual Acuity><Visual impairment><World Health Organization><active followup><age dependent macular degeneration><age group><age induced macular degeneration><age related macular disease><age related macular dystrophy><assess effectiveness><barriers to implementation><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus infectious disease-19><cost><determine effectiveness><effectiveness assessment><effectiveness evaluation><effectiveness testing><effectiveness/implementation hybrid study><effectiveness/implementation study><enroll><evaluate effectiveness><examine effectiveness><eye disorder><eye fundus photography><follow up><follow-up><followed up><followup><fundus camera><glaucomatous><home visit><implementation barriers><implementation challenges><implementation intervention><improved><interventional strategy><intra-ocular pressure><intuitive><new approaches><novel approaches><novel strategies><novel strategy><ocular disease><ocular disorder><older groups><older individuals><older person><ophthalmopathy><optical Doppler tomography><optical coherence Doppler tomography><population based><population-based study><population-level study><post-COVID><post-COVID-19><post-coronavirus disease 2019><prevent><preventing><primary outcome><programs><randomisation><randomization><randomized control trial><randomly assigned><retinal nerve fiber layer><screening><screenings><secondary outcome><senile macular disease><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><short message service><studies of populations><study of the population><success><texting><tonometry><trial design><vision impairment><vision loss><visual loss><visually impaired><volunteer>